More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

Trust in the U.S. healthcare system is eroding — but this decline isn’t happening evenly across the system, one leader pointed out. People largely trust individual clinicians, but they tend to ...

Women are twice as likely as men to experience depression and anxiety. And about one in three women will battle a mental health condition in their lifetime. This is what FamilyWell Health aims to ...

Each year, the HLTH conference gives healthcare leaders a chance to gather and share ideas. The event also gives companies the chance to announce news — oftentimes about new products, partnerships and ...